Insulin pens are medical plastic systems that enable diabetes sufferers to administer their regular insulin doses themselves in a pain-free procedure. Sanofi will perform the final assembly of
Various in vitro and in vivo studies validated a range of Anticalin targeted protein drug candidates designed to bind to a Daiichi’s target and thus an undisclosed payment
Under the deal, SK Chemicals will carry out later-stage clinical phase 2 and 3 trials in Korea. The product is expected to be launched in 2018 in Korea
The trial is designed to assess the safety and efficacy profile of ixmyelocel-T administered via catheter-based injections against placebo. Aastrom Biosciences president and chief executive officer Nick Colangelo
The licensed technology leverages one of BioTime’s HyStem hydrogels for localized delivery of growth factors such as brain-derived neurotrophic factor to improve recovery from stroke. Several pre-clinical studies
FEDI-2Rx range is used in pharmaceutical, biomedical and laboratory applications where installations require hot water sanitization to meet pharmacopoeia standards for purified water and water for injection. QUA
As per the agreement, CSL will leverage Xtend half-life extension technology in a program with known target. CSL will make an upfront payment in addition to preclinical, clinical,
The dose escalation and safety trial will expand to two centres in Atlanta and Ann Arbor, subject to approval by the Institutional Review Board at each institution. Neuralstem
As per the agreement, Myriad will adopt RainDance’s ThunderStorm Target Enrichment System for its next-generation sequencing based Hereditary Cancer Panel (HCP) test. Myriad Genetics president Mark Capone said
The company developed VizuCELL cell lines as a tool to study temporal and spatial dynamic processes in living cells. The tool provides insights into morphological changes and physiological
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.